Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.56B

Market cap10.56B

Price-Earnings ratio

-3.61

Price-Earnings ratio-3.61

Dividend yield

—

Dividend yield—

Average volume

7.81M

Average volume7.81M

High today

$27.80

High today$27.80

Low today

$26.24

Low today$26.24

Open price

$26.40

Open price$26.40

Volume

9.17M

Volume9.17M

52 Week high

$84.28

52 Week high$84.28

52 Week low

$23.15

52 Week low$23.15

MRNA News

TipRanks 1d

Moderna Stock Surges on Canadian Covid Vaccine Demand

Shares in drug giant Moderna (MRNA) were over 5% healthier today after Canada said yes to its Covid vaccine. Elevate Your Investing Strategy: Take advantage of...

TipRanks 1d

Moderna receives Health Canada approval for updated COVID-19 vaccine

Moderna (MRNA) announced that Health Canada has authorized its updated COVID-19 mRNA vaccine, Spikevax, targeting the SARS-CoV-2 LP.8.1 variant, for individuals...

Analyst ratings

63%

of 27 ratings

Buy

22.2%

Hold

63%

Sell

14.8%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.